T. Peled

625 total citations
13 papers, 458 citations indexed

About

T. Peled is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, T. Peled has authored 13 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in T. Peled's work include Hematopoietic Stem Cell Transplantation (6 papers), RNA Interference and Gene Delivery (4 papers) and Mesenchymal stem cell research (3 papers). T. Peled is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), RNA Interference and Gene Delivery (4 papers) and Mesenchymal stem cell research (3 papers). T. Peled collaborates with scholars based in Israel and United States. T. Peled's co-authors include Arnon Nagler, Eitan Fibach, Elizabeth J. Shpall, Efrat Landau, Roy B. Jones, Safa Karandish, J. McMannis, Daniel Couriel, T. Sadeghi and Marcos de Lima and has published in prestigious journals such as Blood, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.

In The Last Decade

T. Peled

13 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Peled Israel 7 326 246 146 110 90 13 458
Chengming Fei China 13 230 0.7× 142 0.6× 234 1.6× 72 0.7× 90 1.0× 25 495
Filippo Centis Italy 8 161 0.5× 241 1.0× 166 1.1× 48 0.4× 121 1.3× 18 485
Zhifu Xiang United States 7 160 0.5× 78 0.3× 176 1.2× 79 0.7× 76 0.8× 22 355
Senichiro Hashimoto Japan 10 305 0.9× 94 0.4× 68 0.5× 41 0.4× 16 0.2× 15 422
Amélie V. Guitart France 11 264 0.8× 115 0.5× 177 1.2× 123 1.1× 67 0.7× 16 443
Agnès Charpentier France 7 161 0.5× 145 0.6× 104 0.7× 44 0.4× 45 0.5× 13 322
Abd Aziz Ibrahim Japan 8 162 0.5× 71 0.3× 172 1.2× 87 0.8× 61 0.7× 12 397
Serena Martinelli Italy 12 125 0.4× 176 0.7× 176 1.2× 27 0.2× 47 0.5× 32 400
Ivan Ivanov United States 15 345 1.1× 489 2.0× 70 0.5× 114 1.0× 19 0.2× 19 616

Countries citing papers authored by T. Peled

Since Specialization
Citations

This map shows the geographic impact of T. Peled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Peled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Peled more than expected).

Fields of papers citing papers by T. Peled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Peled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Peled. The network helps show where T. Peled may publish in the future.

Co-authorship network of co-authors of T. Peled

This figure shows the co-authorship network connecting the top 25 collaborators of T. Peled. A scholar is included among the top collaborators of T. Peled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Peled. T. Peled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mizrahi, Keren, Shifra Ash, T. Peled, et al.. (2014). Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts. Bone Marrow Transplantation. 49(7). 942–949. 3 indexed citations
3.
Lima, Marcos de, J. McMannis, Adrian P. Gee, et al.. (2008). Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplantation. 41(9). 771–778. 183 indexed citations
4.
Peled, T., et al.. (2005). Chelatable cellular copper modulates differentiation and self-renewal of cord blood–derived hematopoietic progenitor cells. Experimental Hematology. 33(10). 1092–1100. 59 indexed citations
5.
Peled, T., Melissa A. Austin, Arik Hasson, et al.. (2004). Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy. 6(4). 344–355. 86 indexed citations
7.
Shpall, E.J., et al.. (2004). Transplantation of ex vivo expanded cord blood. Biology of Blood and Marrow Transplantation. 10(10). 738–738. 3 indexed citations
8.
Peled, T., et al.. (2004). Nicotinamide, a Potent SIRT2 Inhibitor, Delays Differentiation of Hematopoietic Progenitor Cells.. Blood. 104(11). 4142–4142. 1 indexed citations
9.
Shpall, Elizabeth J., Marcos de Lima, K. Arnold Chan, et al.. (2004). Transplantation of Cord Blood Expanded Ex Vivo with Copper Chelator.. Blood. 104(11). 982–982. 2 indexed citations
10.
Peled, T., Arnon Nagler, & Abraham J. Treves. (2003). 226Preferential expansion of cord blood early progenitors enabled by linear polyamine copper chelators. Biology of Blood and Marrow Transplantation. 9(2). 129–130. 1 indexed citations
11.
Peled, T., et al.. (1992). Effect of M20 interleukin-1 inhibitor on normal and leukemic human myeloid progenitors. Blood. 79(5). 1172–1177. 15 indexed citations
12.
Fibach, Eitan, et al.. (1991). Isolation and characterization of HL-60 cell variants with different potentials for spontaneous differentiation.. PubMed. 5(10). 912–6. 6 indexed citations
13.
Fibach, Eitan, Abraham J. Treves, T. Peled, & E. A. Rachmilewitz. (1982). Changes in cell kinetics associated with differentiation of a human promyelocytic cell line (HL60). Cell Proliferation. 15(4). 423–429. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026